About Pioneer Fil-Med IPO
Pioneer Fil-Med IPO Details
Pioneer Fil-Med IPO is a 100% book-built issue of ₹500 crore, comprising a fresh issue of ₹250 crore and an offer for sale (OFS) of ₹250 crore, with a face value of ₹10 per share. The company filed its DRHP with SEBI on March 29, 2026.
The price band and official dates of subscription and listing will be announced by the company later, but the shares are supposed to be listed on the BSE and the NSE platforms. The book-running lead manager of the issue is Nuvama Wealth Management Ltd. and Equirus Capital Pvt. Ltd., while the registrar to the issue is MUFG Intime India Pvt. Ltd.
Pioneer Fil-Med IPO Date & Timeline
Pioneer Fil-Med Ltd. officially filed its Draft Red Herring Prospectus (DRHP) on March 29, 2026. However, the specific Pioneer Fil-Med IPO date and subscription timeline remain unannounced. Following regulatory approval, the company will finalize the price band and bidding dates. Once cleared, the schedule for anchor allotment, public bidding and the final listing on the exchange will be formally disclosed.
Pioneer Fil-Med IPO Timeline
| IPO Open Date | - |
| IPO Close Date | - |
| Basis of Allotment | - |
| Initiation of Refunds | - |
| Credit of Shares to Demat | - |
| Listing Date | - |
| Cut-off time for UPI mandate confirmation | - |
Pioneer Fil-Med IPO Details
| Detail | Description |
|---|---|
| IPO Date | - |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Issue Price Band | - |
| Lot Size | - |
| IPO Type | Fresh Issue + Offer For Sale |
| Total Issue Size | [.] shares (agg. up to ₹ 500 Cr) |
| Reserved for Market Maker | - |
| Fresh Issue(Ex Market Maker) | [.] shares (agg. up to ₹ 250 Cr) |
| Offer for Sale | [.] shares of ₹10 (agg. up to ₹ 250 Cr) |
| Net Offered to Public | - |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 2,55,33,600 shares |
| Share Holding Post Issue | - |
Pioneer Fil-Med IPO GMP (Grey Market Premium)
“Grey Market Premium” or GMP is defined as the rate at which the IPO's shares are traded in the market before they are officially listed on the stock exchange.
The Pioneer Fil-Med IPO GMP is currently trading at ₹[.], reflecting the sentiment of unofficial investors before the official listing. This premium suggests a potential listing price of ₹[.], which is [.]% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.
Company Background
Pioneer Fil-Med Ltd. was incorporated on December 15, 1997, in Delhi, as a private limited company; then, on February 14, 2025, the company transformed into a public limited company to proceed with its listing procedure.
With over 2 decades of operations, the company has been engaged as a manufacturer and supplier of railway and metro equipments and the allied components for the locomotive and coach applications segments in India. The core expertise of Pioneer is in traction equipment design, product simulation and testing.
Operations & Product Range
The core operating model of Pioneer Fil-Med Ltd. is centred around the heavy engineering and industrial manufacturing sectors. The company's key products include the manufacturing and sale of locomotive equipment, various railway and metro products, as well as wind generators. By focusing on these specialised industrial segments, the company mainly targets its B2B customers, including state transport networks, railway operators and entities within the renewable energy ecosystem requiring wind turbine components and allied services.
Facilities & Capacity
To support its manufacturing capabilities, Pioneer Fil-Med Ltd. operates specialised production facilities for heavy engineering and uses integrated IT systems to manage manufacturing processes, inventory, financial data and overall efficiency. They operate as one of the leading wind turbine manufacturers for the supply of 129 wind generators. As Pioneer Fil-Med raises 96% of its income from railway & metro products and allied services.
Brands & Market Presence
Pioneer Fil-Med Ltd. has established a strong market presence as an infrastructure and industrial equipment supplier, consistently delivering critical components like locomotive equipment and wind generators, which have helped it secure a reliable position in the domestic market. The company has maintained a strong relationship with its repeat customers; as a result, the top 10 customers of the company have contributed more than ₹154.92 crore for the period FY25, which is 99% of the total revenue, reflecting strong brand trust and operational reliability in the rail and renewable energy sectors.
Revenue Streams & Business Model
Pioneer Fil-Med Ltd. generates revenue primarily through its manufacturing divisions. The primary revenue sources include the sale of locomotive equipment, railway products, metro products and wind generators, along with income from allied services. For FY25, the company reported a total income of ₹331.12 crore and profit of ₹40.43 crore. The business model involves securing contracts from institutional and corporate clients who require heavy machinery and infrastructure components. This operational structure allows for steady revenue streams from critical infrastructure projects.
Management & Shareholding
The promoters of Pioneer Fil-Med Ltd. are Pioneer Facor IT Infradevelopers Private Limited, Pioneer Procon Private Limited, Pioneer Securities Private Limited, Pioneer Fincap Private Limited, Sushil Kumar Jain, Anil Kumar Agarwal, Rishabh Jain, Akshat Agarwal and Anita Jain. Before the IPO, the promoter held a 78.99% stake and the promoter group held a 16.01% stake in the company, but after the IPO, the promoters’ shareholding will be diluted as the offering includes ₹250 crore OFS by selling shareholders.
Board & Key Management
The leadership of Pioneer Fil-Med Ltd. is led by a team of experts with many years of experience. Sushil Kumar Jain serves as the Chairman and gives strategic direction to the firm. The daily operations are managed by Anil Kumar Agarwal, the Managing Director, along with Whole-Time Directors Rishabh Jain and Akshat Agarwal. To ensure good governance, the board includes Independent Directors Priya Mohpal, Ramakant Pattanaik, Ashok Gupta and Niraj Kumar for honest oversight. Together, this team uses its knowledge to help the company grow and stay successful.
Pioneer Fil-Med IPO Financial Information
Latest Revenue
156.06
₹ Crore
Profit After Tax
25.41
₹ Crore
Net Worth
159.52
₹ Crore
Total Borrowing
18.87
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Reserves & Surplus | Total Borrowing | |||
|---|---|---|---|---|---|---|---|---|---|
| 30 Sep 2025 | 296.15 | 156.06 | 25.41 | 159.52 | — | 18.87 | |||
| 31 Mar 2024 | 225.49 | 326.41 | 40.44 | 137.28 | — | 18.55 | |||
| 31 Mar 2023 | 181.19 | 232.98 | 26.39 | 100.29 | — | 8.51 | |||
| 31 Mar 2022 | 151.88 | 86.067 | 11.17 | 77.36 | — | 21.8 | |||
| Amount in ₹ Crore | |||||||||
Pioneer Fil-Med Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 13.34 % |
| ROCE | 28.79 % |
| Debt/Equity | 0.1 |
| RoNW | 13.94 % |
| PAT Margin | 12.39 % |
| EBITDA Margin | 21.53 % |
| Price to Book Value | - |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 15.84 | - |
| P/E (x) | - | - |
Pioneer Fil-Med IPO Objectives
The company intended to utilise the Pioneer Fil-Med IPO proceeds for strategic purposes:
- Funding the long-term capital expenses
- Funding the working capital requirement
- General corporate purposes
Pioneer Fil-Med IPO Review
Pioneer Fil-Med Ltd. is deeply entrenched in the critical infrastructure and heavy engineering sectors. By supplying locomotive equipment and wind generators, the company aligns itself with long-term macroeconomic themes such as railway modernization and renewable energy expansion.
Financially, the company has shown a growing and healthy financial statement; for FY25, the revenue from operations was reported at ₹326.41 crore and the order book maintained by the company was at ₹350.52 crore. Notably, the top 10 customers of the company contributed more 99.27% revenue for Q2 FY26, which is more than ₹154.92 crore.
However, the investors must be aware of the key strengths, including a long-standing operational history since 1997 and a clear focus on heavy B2B manufacturing, as well as on potential risks, including the inherent cyclicality of infrastructure orders and the heavy reliance on government or large corporate contracts. Overall, the issue presents a traditional infrastructure play for the public markets and investors must check the updates related to the issue.
Conclusion
Pioneer Fil-Med IPO is an opportunity for an investor to invest in a growing company that follows a business model focused on railways, metro products and wind energy infrastructure, where it addresses crucial sectors of the economy. The company has shown growing and healthy statements for the past financial years, which have attracted investors towards the company’s upcoming listing. With this listing, the company aims to fund the manufacturing facilities and operational activities.
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Established track record in manufacturing heavy equipment for railways and metro networks.
Diversified product portfolio that includes renewable energy infrastructure like wind generators.
Strong promoter backing with experienced corporate governance.
Ongoing expansion initiatives, including scaling up specialized equipment lines.
| Sr.no | Description | Date | File |
|---|---|---|---|
| 1 | Filed with SEBI/Exchange | 29/03/2026 | View DRHP |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 0 | 0 | 0 |
| Individual investors (Retail) (Max) | 0 | 0 | 0 |
| S-HNI (Min) | 0 | 0 | 0 |
| S-HNI (Max) | 0 | 0 | 0 |
| B-HNI (Min) | 0 | 0 | 0 |